Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma

Acta Oncologica

Volumn 47, Issue 3, 2008, Pages 479-480

  Glas, Martin ^a,b   Hennemann, Burkhard ^a   Hirschmann, Birgit ^a   Marienhagen, Jörg ^a   Schmidt Wolf, Ingo ^b   Herrlinger, Ulrich ^b   Bogdahn, Ulrich ^a   Hau, Peter ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FRESH FROZEN PLASMA; LOMUSTINE; OCTREOTIDE; PREDNISOLONE; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE CONCENTRATE; FATIGUE; FEMALE; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; LABORATORY TEST; LETTER; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; THERAPY EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CEREBELLAR NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HEMIANOPSIA; HUMANS; LOMUSTINE; MEDULLOBLASTOMA; NEOPLASMS, HORMONE-DEPENDENT; OCTREOTIDE; OPTIC NERVE NEOPLASMS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RADIOTHERAPY, ADJUVANT; RECEPTORS, SOMATOSTATIN; SALVAGE THERAPY; SOMATOSTATIN; VINCRISTINE;

EID: 40949152460     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701678795     Document Type: Letter

References (4)

1. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, et al. Adult medulloblastoma: Prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 2005;252:291-9.
2. Fruhwald MC, O'Dorisio MS, Pietsch T, Reubi JC. High expression of somatostatin receptor 2 (sst2) in medulloblastoma: Implications for diagnosis and therapy. Pediatr Res 1999;45:697-708.
3. Florio T, Morino M, Villa V, Arena S, Corsaro A, Thellung S, et al. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology 2003;144:1574-84.
4. Kwaan HC, Gordon LI. Thrombotic microangiopathy in the cancer patient. Acta Haematol 2001;106:52-6.